Roivant: latest news - GoINPHARMA
Friday, 16 November 2018 - 8:38


Genevant, a new company focusing on gene therapy

British Columbia, Canada-based Arbutus Biopharma and Switzerland-based Roivant Sciences have established Genevant Sciences. The new company will be based in Massachusetts and will aim to develop novel gene therapies (RNA) that will use Arbutus’ Lipid NanoParticle (LNP) technology to release…

New details on the $1bn record private funding for biotech Roivant

The German economic and financial daily Handelsblatt published today a long article about the $1.1bn investment on the Basel-headquartered biotech group Roivant, the largest private funding ever granted to a biotech group. The funding group is led by the Japan-based…